NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines
Medicines Update

The ABPI View

Database of transfers of value to healthcare professionals goes live in June

Disclosure UK – the pharmaceutical industry-led, publicly available database detailing payments and other benefits in kind made by industry to UK healthcare professionals (HCPs) and healthcare organisations (HCOs) will go live in June.


Part of a Europe-wide initiative to increase transparency around the important relationships and collaborations between HCPs and the pharmaceutical industry, the new database will show transfers of value made during 2015, where the HCP has given the pharmaceutical company permission to disclose the information. This includes activities such as speaking at or chairing meetings, advisory board meetings, training services, fees and expenses for services and sponsorship of attendance at meetings.


Since 2012, the pharmaceutical industry in the UK has been publishing details of the annual total payments made to HCPs and HCOs under the ABPI Code of Practice for the Pharmaceutical Industry. The self-regulatory Code of Practice has been operational for more than 50 years and sets standards to ensure that pharmaceutical companies operate in a responsible, ethical and professional manner. This includes appropriate training as well as robust guidance on the promotion of medicines and requirements for interactions with HCPs, patients and the public.


The Disclosure UK database and the disclosure of individual level data is a requirement for all pharmaceutical companies that are signatories to the Code of Practice. Its development signifies a further step forward in greater transparency around the industry/HCP relationships that enable the development of life-saving and life-enhancing medicines for the benefit of patients. Publication of this data is complementary to current NHSE proposals for managing conflicts of interest.


  • For more information about the Disclosure UK database, please visit www.disclosureuk.org.uk
  • For more information about the ABPI Code of Practice for the Pharmaceutical Industry, please visit the Prescription Medicines Code of Practice Authority website www.pmcpa.org.uk


Sandra Auld is Director of ABPI Scotland & UK Therapy Groups and can be contacted at SAuld@abpi.org.uk or 0131 523 0496 if more information is required.